Aadi Bioscience Inc (NASDAQ: AADI) is 46.04% higher on its value in year-to-date trading and has touched a low of $1.21 and a high of $3.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AADI stock was last observed hovering at around $2.86 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $3.00, the stock is 20.77% and 33.17% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing 4.90% at the moment leaves the stock 57.54% off its SMA200. AADI registered 49.75% gain for a year compared to 6-month gain of 84.38%. The firm has a 50-day simple moving average (SMA 50) of $2.2367 and a 200-day simple moving average (SMA200) of $1.900275.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 28.26% loss in the last 1 month and extending the period to 3 months gives it a 55.26%, and is 23.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.44% over the week and 9.21% over the month.
Aadi Bioscience Inc (AADI) has around 89 employees, a market worth around $72.81M and $25.07M in sales. Profit margin for the company is -246.06%. Distance from 52-week low is 147.93% and -16.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-88.77%).
The EPS is expected to grow by 9.02% this year.
Aadi Bioscience Inc (AADI) Top Institutional Holders
63.0 institutions hold shares in Aadi Bioscience Inc (AADI), with institutional investors hold 54.44% of the company’s shares. The shares outstanding are 24.61M, and float is at 20.12M with Short Float at 1.11%. Institutions hold 49.02% of the Float.
The top institutional shareholder in the company is AVORO CAPITAL ADVISORS LLC with over 2.85 million shares valued at $4.16 million. The investor’s holdings represent 10.5494% of the AADI Shares outstanding. As of 2024-06-30, the second largest holder is ACUTA CAPITAL PARTNERS, LLC with 1.85 million shares valued at $2.7 million to account for 6.8471 of the shares outstanding. The other top investors are ALERCE INVESTMENT MANAGEMENT, L.P. which holds 1.63 million shares representing 6.0379% and valued at over $2.38 million, while VANGUARD GROUP INC holds 2.836 of the shares totaling 0.77 million with a market value of $1.12 million.
Aadi Bioscience Inc (AADI) Insider Activity
The most recent transaction is an insider sale by Lennon David James, the company’s CHIEF EXECUTIVE OFFICER. SEC filings show that Lennon David James sold 9,689 shares of the company’s common stock on Oct 03 ’24 at a price of $1.94 per share for a total of $18797.0. Following the sale, the insider now owns 22869.0 shares.
Still, SEC filings show that on Sep 03 ’24, Desai Neil (EXECUTIVE CHAIRMAN) disposed off 40,000 shares at an average price of $1.71 for $68316.0. The insider now directly holds 1,171,543 shares of Aadi Bioscience Inc (AADI).
